title: Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons.
abstract: Ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), cardiotrophin-1 (CT-1), and interleukin 6 (IL-6) comprise a group of structurally related cytokines that promote the survival of subsets of neurons in the developing peripheral nervous system, but the signaling pathways activated by these cytokines that prevent neuronal apoptosis are unclear. Here, we show that these cytokines activate NF-kappaB in cytokine-dependent developing sensory neurons. Preventing NF-kappaB activation with a super-repressor IkappaB-alpha protein markedly reduces the number of neurons that survive in the presence of cytokines, but has no effect on the survival response of the same neurons to brain-derived neurotrophic factors (BDNF), an unrelated neurotrophic factor that binds to a different class of receptors. Cytokine-dependent sensory neurons cultured from embryos that lack p65, a transcriptionally active subunit of NF-kappaB, have a markedly impaired ability to survive in response to cytokines, but respond normally to BDNF. There is increased apoptosis of cytokine- dependent neurons in p65(-/)- embryos in vivo, resulting in a reduction in the total number of these neurons compared with their numbers in wild-type embryos. These results demonstrate that NF-kappaB plays a key role in mediating the survival response of developing neurons to cytokines.
authors.affiliation: School of Biomedical Sciences, Biomedical Science Building, University of St. Andrews, St. Andrews, Fife KY16 9AJ, Scotland.
authors.forename: G
authors.initials: G
authors.lastname: Middleton
authors.forename: M
authors.initials: M
authors.lastname: Hamanoue
authors.forename: Y
authors.initials: Y
authors.lastname: Enokido
authors.forename: S
authors.initials: S
authors.lastname: Wyatt
authors.forename: D
authors.initials: D
authors.lastname: Pennica
authors.forename: E
authors.initials: E
authors.lastname: Jaffray
authors.forename: R T
authors.initials: RT
authors.lastname: Hay
authors.forename: A M
authors.initials: AM
authors.lastname: Davies
mesh_terms: D017209:Apoptosis; D002470:Cell Survival; D020934:Ciliary Neurotrophic Factor / Q000494:pharmacology; D016207:Cytokines / Q000494:pharmacology*; D017950:Ganglia, Sensory / Q000166:cytology / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D006131:Growth Inhibitors / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000494:pharmacology; D016328:NF-kappa B / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009620:Nodose Ganglion / Q000166:cytology / Q000187:drug effects / Q000196:embryology / Q000378:metabolism; D018121:Receptors, Cytokine / Q000096:biosynthesis; D012668:Trigeminal Ganglion / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
chemical_list: D020934:Ciliary Neurotrophic Factor; D016207:Cytokines; D006131:Growth Inhibitors; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D016328:NF-kappa B; D018121:Receptors, Cytokine; C092073:cardiotrophin 1